To determine STAT3 expression in cholangiocarcinoma, we downloaded and analyzed data from the TGCA cohort bile duct cancer CHOL (n = 45; 36 primary tumor and 9 normal tissue samples) from the platform XENA [42]. Here, STAT3 is linked to cholangiocarcinoma.